Clinical Trials · NCT01156779
Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Enrollment
- 31
- Start date
- Jul 2010
- Locations
- 1 site, South Korea
- Primary endpoint
- Assessment of safety